BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2012
View Archived Issues
Novel compounds acting on urate transporter patented by Ardea Bisociences
Read More
Multigene biomarker panels predict early-stage atherosclerosis
Read More
MicroRNA expression signature helps predict response to anticancer agent
Read More
Clinical data published on prucalopride for chronic intestinal pseudo-obstruction
Read More
Jazz Pharmaceuticals merges with Azur Pharma
Read More
Constellation Pharmaceuticals enters collaboration
Read More
Joint research agreement targets novel biofocused anticancer therapies
Read More
Study identifies mediator of drug-induced liver injury and agent to target it
Read More
Milestone developments for Novartis' Lucentis and Galvus in China
Read More
Novel tyrosine-protein kinase BTK inhibitors disclosed by Bristol-Myers Squibb
Read More
Avixgen patents new candidate drugs for HIV infection
Read More
Scientists at PAION prepare novel antifibrinolytic thrombomodulin analogues
Read More
Altos Therapeutics presents new dopamine receptor antagonists
Read More
PROLOR Biotech presents topline data on hGH-CTP
Read More
Phase I trial starts for Celldex Therapeutics' CDX-301
Read More
Bristol-Myers Squibb patents novel HIV attachment inhibitors
Read More
XOMA acquires U.S. rights to Servier franchise
Read More
Concert Pharmaceuticals synthesizes novel HCV NS5B inhibitors
Read More
Treatment begins in first FDA-cleared Cavatak trial
Read More
Research further delineates Kevetrin's mechanism of action
Read More
Soligenix reports results on anthrax vaccine
Read More
Provectus receives regulatory guidance from FDA for PV-10
Read More
FDA approves new pediatric formulations of Viread
Read More
FDA issues complete response letter regarding dapagliflozin
Read More
Protalex advances phase Ib study of PRTX-100
Read More
Wilex completes phase I trial of oral MEK inhibitor
Read More